HECTD3 and breast neoplasm: To address this question, we conducted in vivo tumor cell adhesion assays (Supplementary Fig. 6l) by injecting GFP-labeled PyMT-induced mouse breast tumor cells into WT or Hectd3−/− mice through the tail vein.